In November 2021, the European Pain Federation and Pain Alliance Europe organised the annual SIP forum. For the second year in a row, we met virtually due to the COVID-19 pandemic.
On 31 July, 2021, a programme of highlights from the EAN 2021 Virtual Conress was held online especially to give Chinese neurolgists a taste of Europe's largest neurology meeting.
Latest Posts
-
-
Read the latest reports on EAN clinical fellowships in Innsbruck (AT) and Linz (AT) -
Read the latest reports on EAN clinical fellowships in Dianalund (DK) and London (UK)
-
7th Swiss Narcolepsy Day – 22 January, 2022 -
57th Turkish Neurology Congress – 27 November to 1 December
-
On 3-4 September, 2021, the Virtual Regional Teaching Course in Turkey took place, with more than 250 local medical professionals participating in the online event. -
The latest webinar in a series on inspiring people in neurosciences will focus on the renowned expert on tropical neurology, Prof. Michel Dumas. -
On 31 July, 2021, a programme of highlights from the EAN 2021 Virtual Conress was held online especially to give Chinese neurolgists a taste of Europe's largest neurology meeting.
-
InterviewsCOVID-19 around the World: Clinician interviews on experience and impact of the virus (Argentina) – UPDATE
Follow-up interview with Emilia Gatto, Head of the Neurology Department at Sanatorio de la Trinidad Mitre and Head of the Movement Disorders Section of the Institute of Neuroscience Buenos Aires -
We are happy to announce the first Regional Teaching Course to take place in Nicosia, Cyprus on 11-13 March, 2022. -
On 16 September, 2021 the Virtual EAN-Day took place in Chisinau, Republic of Moldova, organised by the EAN and the Society of Neurologists of the Republic of Moldova. -
Breaking newsCOVID-19Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
This very large epidemiological study calculated stroke incidence, prevalence, mortality, disability-adjusted life-years and the population attributable fraction of disability-adjusted life years associated with 19 risk factors, for 204 countries from 1990 to 2019. -
Breaking newsCOVID-19Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
The aim of this study was to describe the clinical characteristics and outcome of patients with cerebral venous sinus thrombosis after SARS-CoV-2 vaccination. -
Breaking newsCOVID-19Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
This trial tested the safety and efficacy of levosimendan in improving supine slow vital capacity after 12 weeks of treatment in 496 people with amyotrophic lateral sclerosis. -
Breaking newsCOVID-19The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
In this article the authors describe structural changes in cerebral small vessels of patients with COVID-19 and elucidate potential mechanisms underlying the vascular pathology.
Newer Posts